Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Epigenetic Reader Domain
    (2)
  • Histone Methyltransferase
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

h4k20me1

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • UNC926
    UNC-926, UNC 926
    T40121184136-10-4
    UNC926 (UNC-926) inhibits L3MBTL1 (IC50: 3.9 μM). UNC926 also exhibits a low micromolar affinity for L3MBTL3. UNC926 inhibits binding of the 3xMBT domain to H4K20me1. It selectively and dose-dependently inhibits the L3MBTL13xMBT-H4K20me1 interaction. UNC926 has not an effect on the binding of 53BP1 to H4K20me1.
    • $30
    In Stock
    Size
    QTY
  • UNC926 hydrochloride
    T92211782573-49-2
    UNC926 hydrochloride is a methyl-lysine (Kme) reader domain inhibitor.
    • $80
    In Stock
    Size
    QTY
  • MS2928
    T218845
    MS2928 is a selective inhibitor of SETD8 with an IC50 of 0.14 μM for inhibiting the methyltransferase activity of SETD8. It reduces intracellular H4K20me1 levels and inhibits the proliferation of multiple myeloma cells that overexpress SETD8. Additionally, MS2928 suppresses tumor growth in xenograft mouse models of multiple myeloma with SETD8 overexpression. This compound can be utilized in research on SETD8's biological functions and multiple myeloma.
    • Inquiry Price
    Inquiry
    Size
    QTY